Skip to content
Forensic Analysis · Healthcare Providers & Services · as of Nov 8, 2026

Omada Health, Inc. (OMDA)

A forensic read on Omada Health, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

D · Weak — demands caution
Forensic grade
Grey Zone
Financial health
2.3
Distress distance
1
Forensic signals
-5.6%
ROE

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Omada Health, Inc. earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads 2.3, placing it in the Grey zone. 1 forensic signal was flagged in its latest SEC filings, led by return on invested capital.

What the filings flag

-123.7%
FY2025
Return on invested capital. Return on invested capital is -123.7% in the latest fiscal year.

Key fundamentals

Latest Revenue$260.2M
Net Margin-4.9%
Free Cash Flow$12.4M
Return on Equity-5.6%
Debt / Equity0.00x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Omada Health, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Nov 8, 2026. Forensic signals flag probability, not certainty.

See a wrong number? Report an error with the filing it should match.